The Therapeutic Goods Administration (TGA) conducts an annual stakeholder survey to improve the way we work with our stakeholders and to help report on our key performance indicators.
Awareness of the TGA continues to grow in Australia. The 2022 survey found that about 7 out of 10 Australians had heard of the TGA, up by more than 4% from the 2021 survey and more than 17% from the 2020 survey. The survey found that the TGA is trusted to perform its role ethically and with integrity, and most respondents believe we get the balance right between access to therapeutic goods and safety.
Today, many Australians are aware of the TGA because of our response to the COVID-19 pandemic. Pleasingly, most respondents believe our response has been effective. While the pandemic’s impact on our workload has stabilised, it remains busy and evolving.
The 2022 survey found that, while most stakeholders have a positive experience communicating with the TGA, this is not universal. As part of the TGA’s Transformation Program, we are reviewing our enquiry management model to modernise our approach and offer a more consistent and efficient service.
During the last 12 months, the Transformation Program has also made significant progress to address several long-standing barriers our stakeholders have encountered when interacting with us, including the launch of the new TGA website and trial (beta) versions of the ARTG search tool and Database of Adverse Event Notifications (DAEN) – Medicines.
Overall, the 2022 survey indicates that awareness of the TGA continues to grow, and most of our stakeholders—as well as the broader Australian community—hold positive views about the TGA. This presents us with an opportunity to help educate more Australians about the benefits of medicines and medical devices, risk associated with their improper use, and our role as a regulator.
We aim to provide documents in an accessible format. If you're having problems using this document, please contact TGA Education.
Contents
The TGA stakeholder survey report is structured to include a narrative overview of results at the beginning of the report (19 pages) followed by results tables for different stakeholder groups.
- Summary
- The survey approach
- Overview of results
- Written feedback to the TGA
- What happens next
- Appendix A: Consumer results
- Appendix B: Opt-in stakeholder results
- Appendix C: Health professional results
- Appendix D: Abbreviations